ArticleJapanese journal of clinical oncology2026

Impact of prior immune checkpoint inhibitor on trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory analysis of the EN-DEAVOR study.

Yukiya Narita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.